Rocket Pharmaceuticals, Inc. Warrant
RCKTW$0.02 -0.01 (-48.83%)
Company News
ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Law firm investigating Rocket Pharmaceuticals for potential securities fraud related to undisclosed clinical trial protocol changes and serious adverse events in RP-A501 study, which led to a 37% stock price drop.
Deadline Soon: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Law Offices of Frank R. Cruz alerts investors about an upcoming August 11, 2025 deadline to participate in a securities fraud class action lawsuit against Rocket Pharmaceuticals following an FDA clinical hold on a Danon disease treatment trial after a patient's death.
3 Stocks Insiders Are Buying Rapidly Amid Market Volatility
Amid market volatility, insiders have been rapidly buying shares in GameStop, Hallador Energy, and Rocket Pharmaceuticals, likely due to their positive outlook on the companies' prospects.
